Skip to content

Dinoprostone Versus Vaginal Misoprostol for Induction of Labour

Vaginal Dinoprostone Versus Vaginal Misoprostol for Induction of Labour in Post-dated Pregnancy; a Randomized Controlled Study.

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06560515
Enrollment
370
Registered
2024-08-19
Start date
2022-08-01
Completion date
2023-10-31
Last updated
2024-08-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Induced Vaginal Delivery

Brief summary

This randomized controlled study was carried out on 370 pregnant women with gestational age ≥ 40 weeks of different ages and parities at El-Shatby Maternity University Hospital after approval of ethical committee of Alexandria Faculty of Medicine. After assessment for eligibility & enrollment in the study, women were randomly assigned into one of the two study groups, Group (I) received 3 mg vaginal Dinoprostone of maximum 2 doses 6 hours apart and Group (II) received 50 μg of vaginal misoprostol of maximum 2 doses 6 hours apart.

Interventions

induction of labour in women with postdate pregnancy with vaginal dinoprostone vs. vaginal misoprostol

Sponsors

University of Alexandria
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Caregiver, Investigator)

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 45 Years
Healthy volunteers
No

Inclusion criteria

* pregnant women at 40 weeks or beyond * singleton pregnancy * Bishop score 4 or more * fetus in a cephalic presentation * Adequate fetal biophysical profile

Exclusion criteria

* Any signs of labour (Prelabor rupture of membranes) * Grand Multiparous women (parity of 4 or more) * IUFD * fetal weight \> 4 kg * BMI \> 35

Design outcomes

Primary

MeasureTime frameDescription
Sucess of inductionnumber of women who delivered vaginally after inductionpercentage of women with a successful vaginal delivery
Induction to delivery timetime from start of induction till delivery of the fetustime lapse from receiving first dose of induction till delivery of the fetus

Secondary

MeasureTime frameDescription
Postpartum hemorrhageafter delivery of the placentaquantification of amount of postpartum bleeding
neonatal outcomesat 1 and 5 minutes of deliveryApgar Score at 1 and 5 minutes

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026